First Wave BioPharma, Inc. Profile Avatar - Palmy Investing

First Wave BioPharma, Inc.

First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include niclosamid…

Biotechnology
US, Boca Raton [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

First Wave BioPharma, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of FWBI's Analysis
CIK: - CUSIP: 33749P101 LEI: - UEI: -
Secondary Listings
FWBI has no secondary listings inside our databases.